Law360, New York (August 19, 2011, 7:01 PM ET) -- In a decision that underscores the ongoing role of market definition in merger challenges, the Eighth Circuit on Friday nixed a challenge by the Federal Trade Commission to Lundbeck Inc.'s cornering of the market on drugs used to treat heart defects in premature babies.
In a succinct 11-page ruling, the Eighth Circuit backed the lower court's finding that the agency had failed to identify a relevant market since the two drugs at issue were not true competitors because doctors held strong preferences for one or the...
FTC Loses Lundbeck Baby Meds Fight Before 8th Circ.
To view the full article, take a free trial now.
